Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89,152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma.
Ma T, Wiggins CC, Kornatowski BM, Hailat RS, Clayburn AJ, Guo WL, Johnson PW, Senefeld JW, Klassen SA, Baker SE, Bruno KA, Fairweather D, Wright RS, Carter RE, Li C, Joyner MJ, Paneth NS. Ma T, et al. Among authors: li c. Front Med (Lausanne). 2022 Jan 26;8:707895. doi: 10.3389/fmed.2021.707895. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35155458 Free PMC article.
The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent Plasma.
Ma T, Wiggins CC, Kornatowski BM, Hailat RS, Clayburn AC, Guo W, Johnson PW, Senefeld JW, Klassen SA, Baker SE, Bruno KA, Fairweather D, Wright RS, Carter RE, Li C, Joyner MJ, Paneth N. Ma T, et al. Among authors: li c. medRxiv [Preprint]. 2021 Jan 20:2021.01.19.21249678. doi: 10.1101/2021.01.19.21249678. medRxiv. 2021. Update in: Front Med (Lausanne). 2022 Jan 26;8:707895. doi: 10.3389/fmed.2021.707895 PMID: 33501470 Free PMC article. Updated. Preprint.
Assessment of the safety and gut microbiota modulation ability of an infant formula containing Bifidobacterium animalis ssp. lactis CP-9 or Lactobacillus salivarius AP-32 and the effects of the formula on infant growth outcomes: insights from a four-month clinical study in infants under two months old.
Shen SP, Lin HC, Chen JF, Wang HS, Huang YY, Hsia KC, Lin JH, Kuo YW, Li CM, Hsu YC, Tsai SY, Ho HH. Shen SP, et al. Among authors: li cm. BMC Pediatr. 2024 Dec 27;24(1):840. doi: 10.1186/s12887-024-05289-7. BMC Pediatr. 2024. PMID: 39731060 Clinical Trial.
89,152 results
You have reached the last available page of results. Please see the User Guide for more information.